- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02175199
A Comparison of Two Color Contact Lenses in Habitual Clear Contact Lens Wearers
September 14, 2015 updated by: Alcon Research
The purpose of this study is to evaluate the comfort of color contact lenses in a population of clear contact lens wearers who have an interest in wearing color contact lenses.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
151
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Willing to sign an Informed Consent Document or Assent, if applicable.
- Vision correctable to 20/30 Snellen (feet) or better in each eye at distance with pre-study contact lenses.
- Manifest cylinder (at screening) less than or equal to 0.75 diopters (D) in each eye.
- Successful wear of clear/handling tint, single-vision spherical, bi-weekly/ monthly replacement soft contact lenses in both eyes during the past 2 months for a minimum of 5 days per week and 8 hours per day.
- Requires spherical contact lenses within the available range of powers (i.e.,-1.50D to -5.00D in 0.25D steps).
- Interested in wearing contact lenses that change the appearance of the color of the eyes.
- Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
- Any anterior segment infection, inflammation, disease or abnormality that contraindicates contact lens wear (within 7 days of enrollment, or current).
- History of herpetic keratitis.
- Any use of systemic or ocular medications for which contact lens wear could be contraindicated including any use of topical ocular medications that would require instillation during contact lens wear, except for rewetting drops.
- Corneal vascularization greater than 1 millimeter (mm) of penetration.
- Habitual lenses worn in an extended wear modality (routinely sleeping in lenses overnight for 1 night per week or more) over the last 3 months prior to enrollment.
- Previous corneal or refractive surgery or irregular cornea.
- Monovision and monocular (only 1 eye with functional vision) or fit with only 1 lens.
- Anisometropia ≥1.50D (study contact lens prescription).
- History of intolerance or hypersensitivity to any component of the test articles.
- Eye injury or ocular or intra-ocular surgery within the last 6 months (excluding placement of punctal plugs).
- Participation in any clinical study within 30 days of Visit 1.
- Other protocol-specified exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: AIR OPTIX COLORS
Lotrafilcon B contact lenses with color printing worn bilaterally in a daily wear modality 5 days/week, 8 hours/day for 30 days.
|
Other Names:
|
|
Active Comparator: FreshLook COLORBLENDS
Phemfilcon A contact lenses with color printing worn bilaterally in a daily wear modality 5 days/week, 8 hours/day for 30 days with a 2-week replacement.
|
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lens Comfort Likert Response at Day 30
Time Frame: Day 30
|
Subject indicated agreement with the following statement, "These lenses provided the same excellent comfort at the end of the month as they did at the beginning of the month" using a 4-point Likert scale, where 1=Strongly disagree, 2=Disagree; 3=Agree; 4=Strongly agree.
The Top 2 responses (agree, strongly agree) were calculated and reported as a percentage of all responses.
Both eyes were rated together.
This outcome measure was prespecified for the AIR OPTIX COLORS arm only.
|
Day 30
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lens Comfort Likert Response at Day 14
Time Frame: Day 14
|
Subject indicated agreement with the following statement, "These lenses provided the same excellent comfort at the end of two weeks as they did at the beginning of the two weeks" using a 4-point Likert scale, where 1=Strongly disagree, 2=Disagree; 3=Agree; 4=Strongly agree.
The Top 2 responses (agree, strongly agree) were calculated and reported as a percentage of all responses.
Both eyes were rated together.
This outcome measure is prespecified for the AIR OPTIX COLORS arm only.
|
Day 14
|
|
Lens Comfort 1-10 Scale Response
Time Frame: Day 30
|
Subject was instructed, "Please rate your comfort with the study lenses," using a scale from 1-10, where 1=poor and 10=excellent.
Both eyes were rated together.
|
Day 30
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Global Brand Lead, GCRA, Vision Care, Alcon Research
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2014
Primary Completion (Actual)
September 1, 2014
Study Completion (Actual)
September 1, 2014
Study Registration Dates
First Submitted
June 24, 2014
First Submitted That Met QC Criteria
June 24, 2014
First Posted (Estimate)
June 26, 2014
Study Record Updates
Last Update Posted (Estimate)
October 14, 2015
Last Update Submitted That Met QC Criteria
September 14, 2015
Last Verified
September 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M-14-008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on Lotrafilcon B contact lenses with color printing
-
CIBA VISIONCompleted
-
CIBA VISIONUniversity of WaterlooCompleted
-
Alcon ResearchCompleted
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedRefractive Error | Myopia
-
CIBA VISIONCompletedCosmetic Appearance